Gene Symbol | Gene ID | Gene Info |
---|---|---|
Glis3
|
ENSMUSG00000052942.7 | GLIS family zinc finger 3 |
Glis3
|
ENSMUSG00000091294.1 | GLIS family zinc finger 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_28504036_28504436 | Glis3 | 36184 | 0.195223 | 0.43 | 6.1e-04 | Click! |
chr19_28382389_28382540 | Glis3 | 56458 | 0.155613 | -0.34 | 8.8e-03 | Click! |
chr19_28662309_28662504 | Glis3 | 4279 | 0.225562 | 0.30 | 1.9e-02 | Click! |
chr19_28677931_28680368 | Glis3 | 459 | 0.677154 | -0.30 | 2.0e-02 | Click! |
chr19_28453215_28453410 | Glis3 | 87108 | 0.090668 | -0.28 | 2.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_69282071_69282727 | 1.33 |
Gm20236 |
predicted gene, 20236 |
259 |
0.8 |
chr14_69500320_69500976 | 1.33 |
Gm37094 |
predicted gene, 37094 |
258 |
0.81 |
chr7_142576289_142578620 | 1.20 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr13_24760759_24760932 | 1.09 |
Gmnn |
geminin |
595 |
0.68 |
chr8_84703616_84705950 | 1.06 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr10_111594457_111595800 | 1.04 |
4933440J02Rik |
RIKEN cDNA 4933440J02 gene |
855 |
0.55 |
chr14_69495056_69495431 | 0.98 |
Gm37094 |
predicted gene, 37094 |
5147 |
0.11 |
chr14_69276807_69277225 | 0.94 |
Gm20236 |
predicted gene, 20236 |
5124 |
0.1 |
chr1_131276506_131276860 | 0.89 |
Ikbke |
inhibitor of kappaB kinase epsilon |
30 |
0.96 |
chr18_75384437_75388058 | 0.87 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr8_120293928_120294096 | 0.85 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
65556 |
0.09 |
chr11_61142924_61143667 | 0.76 |
Tnfrsf13b |
tumor necrosis factor receptor superfamily, member 13b |
630 |
0.65 |
chr5_88981527_88982249 | 0.74 |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
46078 |
0.17 |
chr13_93673507_93674677 | 0.73 |
Bhmt2 |
betaine-homocysteine methyltransferase 2 |
210 |
0.64 |
chr15_44457385_44458529 | 0.73 |
Pkhd1l1 |
polycystic kidney and hepatic disease 1-like 1 |
404 |
0.83 |
chr7_142996242_142996526 | 0.72 |
Tspan32os |
tetraspanin 32, opposite strand |
5606 |
0.14 |
chr1_181216476_181217012 | 0.71 |
Wdr26 |
WD repeat domain 26 |
4743 |
0.16 |
chr7_16793181_16794023 | 0.70 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
425 |
0.73 |
chr4_132973841_132975368 | 0.70 |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
502 |
0.76 |
chr5_119804344_119805024 | 0.70 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
2983 |
0.24 |
chr11_84820799_84820950 | 0.69 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
1359 |
0.31 |
chr4_144892505_144894616 | 0.69 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
341 |
0.9 |
chr2_147083670_147085642 | 0.68 |
Nkx2-4 |
NK2 homeobox 4 |
789 |
0.65 |
chr8_84706606_84708426 | 0.68 |
Nfix |
nuclear factor I/X |
200 |
0.88 |
chr2_160603365_160603863 | 0.64 |
Gm14221 |
predicted gene 14221 |
16357 |
0.16 |
chr6_82763718_82764495 | 0.63 |
Gm17034 |
predicted gene 17034 |
176 |
0.93 |
chr4_117312229_117313344 | 0.62 |
Rnf220 |
ring finger protein 220 |
12758 |
0.13 |
chr11_18873955_18876215 | 0.62 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr8_70489289_70489965 | 0.60 |
1700020G03Rik |
RIKEN cDNA 1700020G03 gene |
1446 |
0.19 |
chr17_27555141_27555921 | 0.59 |
Hmga1 |
high mobility group AT-hook 1 |
966 |
0.25 |
chr2_121036316_121036674 | 0.59 |
Epb42 |
erythrocyte membrane protein band 4.2 |
186 |
0.9 |
chr1_58796177_58796388 | 0.59 |
Casp8 |
caspase 8 |
805 |
0.48 |
chr17_70850387_70852082 | 0.58 |
Tgif1 |
TGFB-induced factor homeobox 1 |
27 |
0.95 |
chr15_97054420_97055764 | 0.58 |
Slc38a4 |
solute carrier family 38, member 4 |
864 |
0.72 |
chr4_135896003_135896554 | 0.57 |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
884 |
0.41 |
chr2_146098737_146098949 | 0.56 |
Cfap61 |
cilia and flagella associated protein 61 |
51592 |
0.15 |
chr5_92126937_92127088 | 0.56 |
Gm24931 |
predicted gene, 24931 |
8729 |
0.12 |
chr5_97006383_97006630 | 0.56 |
Bmp2k |
BMP2 inducible kinase |
8817 |
0.14 |
chr7_19697995_19699396 | 0.55 |
Apoe |
apolipoprotein E |
74 |
0.92 |
chr7_44478079_44478838 | 0.54 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
4920 |
0.07 |
chr2_167671877_167672567 | 0.53 |
Gm14320 |
predicted gene 14320 |
10113 |
0.1 |
chr10_118867942_118869119 | 0.52 |
Dyrk2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
231 |
0.89 |
chr4_147969208_147969498 | 0.52 |
Nppb |
natriuretic peptide type B |
16435 |
0.09 |
chr2_30417827_30418146 | 0.52 |
Ptpa |
protein phosphatase 2 protein activator |
1684 |
0.2 |
chr6_101271319_101271470 | 0.52 |
9530086O07Rik |
RIKEN cDNA 9530086O07 gene |
17116 |
0.17 |
chr5_115433807_115437237 | 0.51 |
Msi1 |
musashi RNA-binding protein 1 |
24 |
0.93 |
chr6_108306863_108307717 | 0.49 |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
48964 |
0.16 |
chr2_172255856_172256129 | 0.49 |
Mc3r |
melanocortin 3 receptor |
7500 |
0.18 |
chr1_58964778_58965097 | 0.49 |
Trak2 |
trafficking protein, kinesin binding 2 |
8492 |
0.15 |
chr9_48689387_48689590 | 0.49 |
Nnmt |
nicotinamide N-methyltransferase |
84335 |
0.09 |
chr14_20478404_20479012 | 0.48 |
Anxa7 |
annexin A7 |
1200 |
0.35 |
chr6_4903006_4904131 | 0.48 |
Ppp1r9a |
protein phosphatase 1, regulatory subunit 9A |
136 |
0.95 |
chr13_12033129_12034063 | 0.48 |
Gm47493 |
predicted gene, 47493 |
18459 |
0.21 |
chr13_109211684_109213183 | 0.48 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
48221 |
0.19 |
chr18_32550160_32550591 | 0.48 |
Gypc |
glycophorin C |
9605 |
0.2 |
chr17_48300015_48301474 | 0.47 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr3_121891181_121891529 | 0.47 |
Gm42593 |
predicted gene 42593 |
28513 |
0.14 |
chr4_46038779_46040179 | 0.47 |
Tmod1 |
tropomodulin 1 |
270 |
0.92 |
chr8_70500810_70501374 | 0.46 |
Crlf1 |
cytokine receptor-like factor 1 |
41 |
0.94 |
chr10_103027884_103029519 | 0.46 |
Alx1 |
ALX homeobox 1 |
74 |
0.97 |
chr5_115948395_115949019 | 0.46 |
Cit |
citron |
2383 |
0.26 |
chr6_117900348_117901073 | 0.46 |
Hnrnpf |
heterogeneous nuclear ribonucleoprotein F |
370 |
0.73 |
chr14_60735927_60737075 | 0.46 |
Spata13 |
spermatogenesis associated 13 |
3595 |
0.24 |
chr17_34117887_34119117 | 0.45 |
Brd2 |
bromodomain containing 2 |
13 |
0.89 |
chr5_123040956_123041124 | 0.45 |
Morn3 |
MORN repeat containing 3 |
3328 |
0.11 |
chr13_108775293_108775893 | 0.44 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
84573 |
0.1 |
chr15_98833260_98833542 | 0.44 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1880 |
0.16 |
chr2_153345876_153347096 | 0.44 |
2500004C02Rik |
RIKEN cDNA 2500004C02 gene |
413 |
0.6 |
chr10_17684003_17684189 | 0.44 |
Gm47771 |
predicted gene, 47771 |
25583 |
0.18 |
chr2_103958009_103958847 | 0.44 |
Lmo2 |
LIM domain only 2 |
433 |
0.78 |
chr4_43479376_43479653 | 0.43 |
Sit1 |
suppression inducing transmembrane adaptor 1 |
3708 |
0.1 |
chrX_7966155_7966575 | 0.43 |
Gata1 |
GATA binding protein 1 |
1545 |
0.2 |
chr8_57320946_57324000 | 0.43 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr5_101663868_101665354 | 0.43 |
Nkx6-1 |
NK6 homeobox 1 |
385 |
0.86 |
chr3_127790290_127791036 | 0.43 |
Tifa |
TRAF-interacting protein with forkhead-associated domain |
8 |
0.96 |
chr2_152829459_152831273 | 0.43 |
Bcl2l1 |
BCL2-like 1 |
56 |
0.96 |
chr2_167039678_167039965 | 0.42 |
Znfx1 |
zinc finger, NFX1-type containing 1 |
3674 |
0.12 |
chr10_126979215_126980392 | 0.42 |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
774 |
0.42 |
chr4_140683994_140684402 | 0.42 |
Gm13025 |
predicted gene 13025 |
4445 |
0.14 |
chr3_89391665_89393338 | 0.42 |
Zbtb7b |
zinc finger and BTB domain containing 7B |
432 |
0.43 |
chr9_82974428_82975413 | 0.41 |
Phip |
pleckstrin homology domain interacting protein |
488 |
0.83 |
chr17_25087394_25087774 | 0.41 |
Ift140 |
intraflagellar transport 140 |
3087 |
0.14 |
chr5_35160468_35161280 | 0.40 |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
55108 |
0.11 |
chr3_89395650_89396522 | 0.40 |
Gm15417 |
predicted gene 15417 |
90 |
0.9 |
chr16_33751298_33751922 | 0.40 |
Heg1 |
heart development protein with EGF-like domains 1 |
1546 |
0.4 |
chr10_53435337_53435500 | 0.40 |
Gm36229 |
predicted gene, 36229 |
25536 |
0.12 |
chr7_38106410_38107383 | 0.40 |
Ccne1 |
cyclin E1 |
12 |
0.97 |
chr11_95337114_95338152 | 0.39 |
Gm11521 |
predicted gene 11521 |
225 |
0.77 |
chr13_94882690_94883964 | 0.39 |
Otp |
orthopedia homeobox |
727 |
0.7 |
chr18_15345788_15346105 | 0.39 |
A830021F12Rik |
RIKEN cDNA A830021F12 gene |
5988 |
0.22 |
chr12_80943606_80943890 | 0.39 |
Gm20337 |
predicted gene, 20337 |
1648 |
0.24 |
chr18_80707533_80708715 | 0.39 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
49 |
0.97 |
chr3_89138382_89138543 | 0.39 |
Pklr |
pyruvate kinase liver and red blood cell |
1839 |
0.14 |
chr7_16783986_16784158 | 0.38 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
666 |
0.56 |
chr14_63240390_63241194 | 0.38 |
Gata4 |
GATA binding protein 4 |
4456 |
0.2 |
chr8_71475930_71476834 | 0.38 |
Dda1 |
DET1 and DDB1 associated 1 |
5971 |
0.08 |
chr7_141132681_141133038 | 0.38 |
Ptdss2 |
phosphatidylserine synthase 2 |
306 |
0.76 |
chr12_4592745_4593903 | 0.38 |
Itsn2 |
intersectin 2 |
262 |
0.51 |
chr14_31124934_31125916 | 0.38 |
Smim4 |
small integral membrane protein 4 |
3413 |
0.14 |
chr4_154022768_154023789 | 0.38 |
Smim1 |
small integral membrane protein 1 |
1045 |
0.34 |
chr8_122536554_122537967 | 0.38 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
14069 |
0.09 |
chr7_45018032_45018680 | 0.38 |
Rras |
related RAS viral (r-ras) oncogene |
273 |
0.72 |
chr2_91949326_91950727 | 0.38 |
Dgkz |
diacylglycerol kinase zeta |
285 |
0.84 |
chr4_133752701_133753843 | 0.37 |
Arid1a |
AT rich interactive domain 1A (SWI-like) |
339 |
0.85 |
chr7_29452917_29453938 | 0.37 |
Sipa1l3 |
signal-induced proliferation-associated 1 like 3 |
52025 |
0.1 |
chr4_135203168_135204139 | 0.37 |
Runx3 |
runt related transcription factor 3 |
49217 |
0.1 |
chr4_141720790_141721430 | 0.37 |
Ddi2 |
DNA-damage inducible protein 2 |
2309 |
0.21 |
chr19_16132684_16134036 | 0.37 |
Gnaq |
guanine nucleotide binding protein, alpha q polypeptide |
64 |
0.98 |
chr2_164441103_164441802 | 0.37 |
Sdc4 |
syndecan 4 |
1734 |
0.18 |
chr15_77904578_77904798 | 0.36 |
Txn2 |
thioredoxin 2 |
11012 |
0.15 |
chr3_138130180_138131364 | 0.36 |
Mttp |
microsomal triglyceride transfer protein |
605 |
0.65 |
chr10_53596930_53598102 | 0.36 |
Asf1a |
anti-silencing function 1A histone chaperone |
64 |
0.58 |
chr1_171442089_171442654 | 0.36 |
F11r |
F11 receptor |
4792 |
0.1 |
chr12_103336507_103336792 | 0.35 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
85 |
0.72 |
chrX_159650282_159650702 | 0.35 |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
22951 |
0.2 |
chr16_20672828_20674037 | 0.35 |
Eif4g1 |
eukaryotic translation initiation factor 4, gamma 1 |
7 |
0.93 |
chr8_70493071_70496051 | 0.35 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr19_53194082_53195694 | 0.35 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr11_95833615_95836077 | 0.35 |
Abi3 |
ABI gene family, member 3 |
1044 |
0.33 |
chr16_38362450_38363226 | 0.34 |
Popdc2 |
popeye domain containing 2 |
593 |
0.63 |
chr11_96331807_96334248 | 0.34 |
Hoxb3 |
homeobox B3 |
4965 |
0.08 |
chr6_51379176_51380008 | 0.34 |
Gm6559 |
predicted gene 6559 |
118 |
0.96 |
chr15_62121962_62122411 | 0.34 |
Pvt1 |
Pvt1 oncogene |
23157 |
0.25 |
chr15_91369976_91370127 | 0.34 |
Slc2a13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
42166 |
0.18 |
chr2_14055011_14056286 | 0.34 |
Hacd1 |
3-hydroxyacyl-CoA dehydratase 1 |
372 |
0.82 |
chr13_45511245_45511573 | 0.33 |
Gmpr |
guanosine monophosphate reductase |
2431 |
0.33 |
chr16_92822245_92822888 | 0.33 |
Runx1 |
runt related transcription factor 1 |
3212 |
0.32 |
chr1_160988097_160988378 | 0.33 |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
1140 |
0.22 |
chr7_142658126_142659753 | 0.33 |
Igf2 |
insulin-like growth factor 2 |
550 |
0.47 |
chr5_124248924_124250266 | 0.33 |
Pitpnm2 |
phosphatidylinositol transfer protein, membrane-associated 2 |
144 |
0.92 |
chr2_130634489_130636508 | 0.32 |
Lzts3 |
leucine zipper, putative tumor suppressor family member 3 |
2597 |
0.15 |
chr3_129216664_129219042 | 0.32 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chrX_12001809_12002609 | 0.32 |
Gm14512 |
predicted gene 14512 |
17741 |
0.23 |
chr11_117782674_117783995 | 0.32 |
Tmc8 |
transmembrane channel-like gene family 8 |
676 |
0.39 |
chr18_65092314_65092688 | 0.32 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
9447 |
0.25 |
chr11_78303369_78303520 | 0.32 |
Spag5 |
sperm associated antigen 5 |
1789 |
0.16 |
chr8_107095938_107096820 | 0.32 |
Terf2 |
telomeric repeat binding factor 2 |
135 |
0.67 |
chr16_22881087_22881238 | 0.32 |
Ahsg |
alpha-2-HS-glycoprotein |
10115 |
0.11 |
chr14_76532606_76533942 | 0.31 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6658 |
0.2 |
chr10_93833520_93834579 | 0.31 |
Usp44 |
ubiquitin specific peptidase 44 |
231 |
0.91 |
chr9_64533785_64534038 | 0.31 |
Megf11 |
multiple EGF-like-domains 11 |
12988 |
0.25 |
chr19_55746711_55749175 | 0.31 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
5098 |
0.32 |
chr4_124605630_124606127 | 0.31 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
36688 |
0.11 |
chr7_47357377_47358685 | 0.31 |
Mrgpra1 |
MAS-related GPR, member A1 |
3791 |
0.17 |
chr9_107288899_107290229 | 0.31 |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
183 |
0.89 |
chr13_109632540_109633637 | 0.31 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
308 |
0.95 |
chr11_95896737_95897369 | 0.31 |
B4galnt2 |
beta-1,4-N-acetyl-galactosaminyl transferase 2 |
17838 |
0.09 |
chr5_29467659_29468760 | 0.31 |
Mnx1 |
motor neuron and pancreas homeobox 1 |
10261 |
0.16 |
chr14_55105801_55106847 | 0.30 |
Ap1g2 |
adaptor protein complex AP-1, gamma 2 subunit |
57 |
0.94 |
chr1_135836765_135837624 | 0.30 |
Tnnt2 |
troponin T2, cardiac |
781 |
0.54 |
chr3_69588620_69588951 | 0.30 |
B3galnt1 |
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 |
10175 |
0.18 |
chr9_66157901_66159171 | 0.30 |
Dapk2 |
death-associated protein kinase 2 |
301 |
0.9 |
chr15_77837622_77838284 | 0.30 |
Gm22107 |
predicted gene, 22107 |
2803 |
0.2 |
chr17_84185673_84188034 | 0.30 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
1094 |
0.34 |
chr7_127090806_127091953 | 0.30 |
AI467606 |
expressed sequence AI467606 |
20 |
0.93 |
chr11_95009478_95010181 | 0.30 |
Samd14 |
sterile alpha motif domain containing 14 |
50 |
0.95 |
chr3_115758693_115759280 | 0.30 |
Gm9889 |
predicted gene 9889 |
43836 |
0.13 |
chr17_56728100_56728600 | 0.30 |
Fut4-ps1 |
fucosyltransferase 4, pseudogene 1 |
5878 |
0.1 |
chr16_23102639_23103369 | 0.30 |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
4440 |
0.07 |
chr4_63152318_63152930 | 0.30 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
1549 |
0.36 |
chr4_130913313_130914133 | 0.30 |
Laptm5 |
lysosomal-associated protein transmembrane 5 |
365 |
0.85 |
chr1_21963069_21963530 | 0.30 |
Kcnq5 |
potassium voltage-gated channel, subfamily Q, member 5 |
1357 |
0.56 |
chr7_133114831_133116529 | 0.30 |
Ctbp2 |
C-terminal binding protein 2 |
2981 |
0.2 |
chr1_74027276_74028287 | 0.29 |
Tns1 |
tensin 1 |
9352 |
0.23 |
chr1_136139800_136140905 | 0.29 |
Kif21b |
kinesin family member 21B |
8898 |
0.11 |
chr4_128805343_128806839 | 0.29 |
Zfp362 |
zinc finger protein 362 |
46 |
0.97 |
chr1_171189020_171190029 | 0.29 |
Pcp4l1 |
Purkinje cell protein 4-like 1 |
6744 |
0.09 |
chr9_111055888_111057545 | 0.29 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr5_122101950_122102247 | 0.29 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
301 |
0.86 |
chr12_109452854_109454456 | 0.29 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
0 |
0.96 |
chr2_164772892_164773805 | 0.29 |
Ube2c |
ubiquitin-conjugating enzyme E2C |
3445 |
0.09 |
chr7_45797605_45798943 | 0.29 |
Lmtk3 |
lemur tyrosine kinase 3 |
10526 |
0.07 |
chr14_54971177_54971539 | 0.29 |
Gm29015 |
predicted gene 29015 |
1671 |
0.12 |
chr9_21961394_21962913 | 0.29 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr11_33202043_33204837 | 0.29 |
Tlx3 |
T cell leukemia, homeobox 3 |
149 |
0.86 |
chr1_172501767_172503923 | 0.29 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr11_94242616_94243821 | 0.29 |
Wfikkn2 |
WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 |
511 |
0.76 |
chr2_181081653_181082036 | 0.29 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
13577 |
0.13 |
chr3_127123282_127124895 | 0.29 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr6_52174920_52176658 | 0.29 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
554 |
0.41 |
chr1_85735264_85735792 | 0.29 |
A630001G21Rik |
RIKEN cDNA A630001G21 gene |
1026 |
0.4 |
chr18_11058575_11059292 | 0.29 |
Gata6 |
GATA binding protein 6 |
114 |
0.97 |
chr3_95673620_95674691 | 0.28 |
Adamtsl4 |
ADAMTS-like 4 |
2996 |
0.14 |
chr12_103656514_103657055 | 0.28 |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
318 |
0.81 |
chr9_58656515_58657338 | 0.28 |
Rec114 |
REC114 meiotic recombination protein |
2366 |
0.27 |
chr4_135152193_135153995 | 0.28 |
Runx3 |
runt related transcription factor 3 |
66 |
0.97 |
chr18_80712423_80713681 | 0.28 |
Nfatc1 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
6 |
0.98 |
chr16_17560824_17562372 | 0.28 |
P2rx6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
287 |
0.52 |
chr6_49218211_49218700 | 0.28 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
3498 |
0.19 |
chr1_133245733_133247220 | 0.28 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
370 |
0.84 |
chr7_132812969_132814132 | 0.28 |
Fam53b |
family with sequence similarity 53, member B |
22 |
0.97 |
chr5_119834833_119836185 | 0.28 |
Tbx5 |
T-box 5 |
646 |
0.68 |
chr4_134766990_134768275 | 0.28 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
392 |
0.86 |
chr1_131971821_131972623 | 0.28 |
Slc45a3 |
solute carrier family 45, member 3 |
1613 |
0.26 |
chr12_110971721_110972289 | 0.28 |
Ankrd9 |
ankyrin repeat domain 9 |
6250 |
0.12 |
chr5_137749206_137749783 | 0.28 |
Tsc22d4 |
TSC22 domain family, member 4 |
1688 |
0.19 |
chr14_75837036_75838166 | 0.28 |
Gm48931 |
predicted gene, 48931 |
3885 |
0.16 |
chr5_144645368_144645519 | 0.28 |
Gm6272 |
predicted pseudogene 6272 |
78354 |
0.08 |
chr19_53325039_53326410 | 0.28 |
Gm30541 |
predicted gene, 30541 |
1 |
0.97 |
chr3_57425387_57425767 | 0.28 |
Tm4sf4 |
transmembrane 4 superfamily member 4 |
263 |
0.93 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.1 | 0.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.4 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.4 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.1 | 0.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.1 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.7 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.4 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.3 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.1 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.5 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.2 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.3 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 0.1 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.1 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.8 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.2 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.1 | 0.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.2 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.4 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.1 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.2 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.2 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.1 | 0.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.1 | 0.1 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.7 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.0 | 0.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.1 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.0 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.0 | 0.2 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.0 | 0.1 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.0 | 0.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.9 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.2 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.0 | 0.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.0 | 0.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.0 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.0 | 0.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.0 | 0.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.0 | 0.0 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.2 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.0 | 0.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.0 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.0 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.0 | 0.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.0 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.0 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.0 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.0 | 0.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 0.3 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.1 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.1 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.0 | 0.2 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.0 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.0 | 0.0 | GO:0061083 | regulation of protein refolding(GO:0061083) |
0.0 | 0.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.0 | 0.0 | GO:0060214 | endocardium formation(GO:0060214) |
0.0 | 0.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.0 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.0 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.0 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.8 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.0 | 0.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0048880 | sensory system development(GO:0048880) |
0.0 | 0.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.0 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.0 | 0.2 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.0 | GO:0014891 | skeletal muscle atrophy(GO:0014732) striated muscle atrophy(GO:0014891) |
0.0 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.0 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.0 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.0 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.0 | 0.1 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.1 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.2 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.0 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.0 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.0 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.1 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.0 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.0 | 0.0 | GO:0036166 | phenotypic switching(GO:0036166) |
0.0 | 0.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.0 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.2 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.0 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 0.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.3 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 1.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.3 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 4.0 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.2 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.0 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 0.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.6 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.3 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 0.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.0 | 0.1 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.2 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.6 | GO:0004119 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.0 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 1.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.0 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 1.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 1.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.9 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 1.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.0 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |